Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies

By Hoare C.M.   DeBouck P.   Wiseman A.  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 273-275

Elsevier

Access to resources Recommend Favorite

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

By Ehrlich H.J.   Pavlova B.G.   Fritsch S.   Poellabauer E.-M.   Loew-Baselli A.   Obermann-Slupetzky O.   Maritsch F.   Cil I.   Dorner F.   Barrett P.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells

By Zhang M.   Emerson S.U.   Nguyen H.   Engle R.E.   Govindarajan S.   Gerin J.L.   Purcell R.H.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 853-857

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants

By Zangwill K.M.   Greenberg D.P.   Chiu C.-Y.   Mendelman P.   Wong V.K.   Chang S.-J.   Partridge S.   Ward J.I.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1894-1900

Elsevier

Access to resources Recommend Favorite

The immunogenicity in humans of a botulinum type F vaccine

By Montgomery V.A.   Makuch R.S.   Brown J.E.   Hack D.C.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 728-735

Elsevier

Access to resources Recommend Favorite